Phibro Animal Health Corporation (PAHC)
NASDAQ: PAHC · Real-Time Price · USD
29.41
-0.32 (-1.09%)
At close: Jul 18, 2025, 4:00 PM
29.41
0.00 (0.02%)
After-hours: Jul 18, 2025, 7:04 PM EDT
Phibro Animal Health Stock Forecast
Stock Price Forecast
The 4 analysts that cover Phibro Animal Health stock have a consensus rating of "Hold" and an average price target of $24.5, which forecasts a -16.68% decrease in the stock price over the next year. The lowest target is $15 and the highest is $35.
Price Target: $24.5 (-16.68%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Phibro Animal Health stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 1 |
| Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Hold → Buy Upgrades $25 → $35 | Hold → Buy | Upgrades | $25 → $35 | +19.03% | Jul 7, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $21 → $26 | Hold | Maintains | $21 → $26 | -11.58% | Jun 25, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $20 → $21 | Hold | Maintains | $20 → $21 | -28.58% | May 8, 2025 |
| Barclays | Barclays | Sell Maintains $20 → $22 | Sell | Maintains | $20 → $22 | -25.18% | Feb 10, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $20 → $25 | Hold | Maintains | $20 → $25 | -14.98% | Dec 17, 2024 |
Financial Forecast
Revenue This Year
1.30B
from 1.02B
Increased by 28.13%
Revenue Next Year
1.48B
from 1.30B
Increased by 13.11%
EPS This Year
2.08
from 0.06
Increased by 3,388.47%
EPS Next Year
2.38
from 2.08
Increased by 14.38%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 1.3B | 1.5B | 1.6B | |
| Avg | 1.3B | 1.5B | 1.5B | |
| Low | 1.2B | 1.4B | 1.4B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 32.6% | 18.2% | 7.3% | |
| Avg | 28.1% | 13.1% | 3.1% | |
| Low | 22.7% | 7.8% | -2.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 2.16 | 2.55 | 2.82 | |
| Avg | 2.08 | 2.38 | 2.68 | |
| Low | 1.98 | 2.16 | 2.52 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 3,526.3% | 22.6% | 18.7% | |
| Avg | 3,388.5% | 14.4% | 12.7% | |
| Low | 3,218.8% | 3.6% | 5.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.